These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29727163)

  • 1. Aminoguanidine Hydrazone Derivatives as Nonpeptide NPFF1 Receptor Antagonists Reverse Opioid Induced Hyperalgesia.
    Hammoud H; Elhabazi K; Quillet R; Bertin I; Utard V; Laboureyras E; Bourguignon JJ; Bihel F; Simonnet G; Simonin F; Schmitt M
    ACS Chem Neurosci; 2018 Nov; 9(11):2599-2609. PubMed ID: 29727163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents.
    Elhabazi K; Humbert JP; Bertin I; Quillet R; Utard V; Schneider S; Schmitt M; Bourguignon JJ; Laboureyras E; Ben Boujema M; Simonnet G; Ancel C; Simonneaux V; Beltramo M; Bucher B; Sorg T; Meziane H; Schneider E; Petit-Demoulière B; Ilien B; Bihel F; Simonin F
    Neuropharmacology; 2017 May; 118():188-198. PubMed ID: 28288815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
    Elhabazi K; Trigo JM; Mollereau C; Moulédous L; Zajac JM; Bihel F; Schmitt M; Bourguignon JJ; Meziane H; Petit-demoulière B; Bockel F; Maldonado R; Simonin F
    Br J Pharmacol; 2012 Jan; 165(2):424-35. PubMed ID: 21718302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an
    Quillet R; Schneider S; Utard V; Drieu la Rochelle A; Elhabazi K; Henningsen JB; Gizzi P; Schmitt M; Kugler V; Simonneaux V; Ilien B; Simonin F; Bihel F
    J Med Chem; 2021 Jun; 64(11):7555-7564. PubMed ID: 34008968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.
    Simonin F; Schmitt M; Laulin JP; Laboureyras E; Jhamandas JH; MacTavish D; Matifas A; Mollereau C; Laurent P; Parmentier M; Kieffer BL; Bourguignon JJ; Simonnet G
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):466-71. PubMed ID: 16407169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a peptidomimetic antagonist of neuropeptide FF receptors for the prevention of opioid-induced hyperalgesia.
    Bihel F; Humbert JP; Schneider S; Bertin I; Wagner P; Schmitt M; Laboureyras E; Petit-Demoulière B; Schneider E; Mollereau C; Simonnet G; Simonin F; Bourguignon JJ
    ACS Chem Neurosci; 2015 Mar; 6(3):438-45. PubMed ID: 25588572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors.
    Gealageas R; Schneider S; Humbert JP; Bertin I; Schmitt M; Laboureyras E; Dugave C; Mollereau C; Simonnet G; Bourguignon JJ; Simonin F; Bihel F
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7471-4. PubMed ID: 23131340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blockade of neuropeptide FF receptor 1 and 2 differentially contributed to the modulating effects on fentanyl-induced analgesia and hyperalgesia in mice.
    Chen D; Zhang M; Zhang Q; Wu S; Yu B; Zhang X; Hu X; Zhang S; Yang Z; Kuang J; Xu B; Fang Q
    Eur J Pharmacol; 2024 Apr; 969():176457. PubMed ID: 38395375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance.
    Wang ZL; Li N; Wang P; Tang HH; Han ZL; Song JJ; Li XH; Yu HP; Zhang T; Zhang R; Xu B; Zhang MN; Fang Q; Wang R
    Neuropharmacology; 2016 Sep; 108():364-72. PubMed ID: 26970017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors.
    Elhabazi K; Humbert JP; Bertin I; Schmitt M; Bihel F; Bourguignon JJ; Bucher B; Becker JA; Sorg T; Meziane H; Petit-Demoulière B; Ilien B; Simonin F
    Neuropharmacology; 2013 Dec; 75():164-71. PubMed ID: 23911743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bifunctional-biased mu-opioid agonist-neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects.
    Drieu la Rochelle A; Guillemyn K; Dumitrascuta M; Martin C; Utard V; Quillet R; Schneider S; Daubeuf F; Willemse T; Mampuys P; Maes BUW; Frossard N; Bihel F; Spetea M; Simonin F; Ballet S
    Pain; 2018 Sep; 159(9):1705-1718. PubMed ID: 29708942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists.
    Nguyen T; Decker AM; Langston TL; Mathews KM; Siemian JN; Li JX; Harris DL; Runyon SP; Zhang Y
    ACS Chem Neurosci; 2017 Oct; 8(10):2290-2308. PubMed ID: 28737888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors.
    Journigan VB; Mésangeau C; Vyas N; Eans SO; Cutler SJ; McLaughlin JP; Mollereau C; McCurdy CR
    J Med Chem; 2014 Nov; 57(21):8903-27. PubMed ID: 25268943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
    Zhang R; Xu B; Zhang MN; Zhang T; Wang ZL; Zhao G; Zhao GH; Li N; Fang Q; Wang R
    Eur J Pharmacol; 2017 Oct; 813():122-129. PubMed ID: 28755985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist.
    Fang Q; Wang YQ; He F; Guo J; Guo J; Chen Q; Wang R
    Regul Pept; 2008 Apr; 147(1-3):45-51. PubMed ID: 18276024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide FF receptors have opposing modulatory effects on nociception.
    Lameh J; Bertozzi F; Kelly N; Jacobi PM; Nguyen D; Bajpai A; Gaubert G; Olsson R; Gardell LR
    J Pharmacol Exp Ther; 2010 Jul; 334(1):244-54. PubMed ID: 20354177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice.
    Wang YQ; Guo J; Wang SB; Fang Q; He F; Wang R
    Peptides; 2008 Jul; 29(7):1183-90. PubMed ID: 18406009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors' Activation.
    Wojciechowski P; Andrzejewski K; Kaczyńska K
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanidine-to-piperidine switch affords high affinity small molecule NPFF ligands with preference for NPFF1-R and NPFF2-R subtypes.
    Galal KA; Obeng S; Pallares VLC; Senetra A; Seabra MABL; Awad A; McCurdy CR
    Eur J Med Chem; 2024 Apr; 269():116330. PubMed ID: 38522114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide FF and prolactin-releasing peptide decrease cortical excitability through activation of NPFF receptors.
    Buffel I; Meurs A; Portelli J; Raedt R; De Herdt V; Sioncke L; Wadman W; Bihel F; Schmitt M; Vonck K; Bourguignon JJ; Simonin F; Smolders I; Boon P
    Epilepsia; 2015 Mar; 56(3):489-98. PubMed ID: 25684325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.